694
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of music therapy on improving treatment motivation and emotion in female patients with methamphetamine use disorder: A randomized controlled trial

, MA, , MD, , MA, , MA, , MA, , MA, , MD, PhD, , MD, , MD, PhD, , MD, PhD & , MD, PhDORCID Icon show all

References

  • Office of China National Narcotics Control Commission. Annual Report on Drug Control in China. Beijing: Office of Drug Control; 2017.
  • United Nations Office on Drugs and Crime, World Health Organization. International Standards for the Treatment of Drug Use Disorders. Vienna: United Nations Office on Drugs and Crime; 2016.
  • Greenfield L, Burgdorf K, Chen X, Porowski A, Roberts T, Herrell J. Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies. Am J Drug Alcohol Abuse. 2004;30(3):537–550.
  • Chauchard E, Levin KH, Copersino ML, Heishman SJ, Gorelick DA. Motivations to quit cannabis use in an adult non-treatment sample: are they related to relapse? Addict Behav. 2013;38(9):2422–2427.
  • Kelly JF, Rudolf M. Dropout from 12-step self-help groups: prevalence, predictors, and counteracting treatment influences. J Subst Abuse Treat. 2003;24(3):241–250.
  • Stewart JA, Egloff N, von Känel R, Grolimund J, Studer M, Grosse Holtforth M. Motivation for psychological treatment predicts favorable outcomes in multimodal interdisciplinary treatment for chronic somatoform pain. Psychother Psychosom. 2017;86(1):60–61.
  • Thaler L, Israel M, Antunes JM, Sarin S, Zuroff DC, Steiger H. An examination of the role of autonomous versus controlled motivation in predicting inpatient treatment outcome for anorexia nervosa. Int J Eat Disord. 2016;49(6):626–629.
  • Cooper J, Borland R, Mckee SA, Yong HH, Dugué PA. Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study. Addiction 2016;111(8):1438–1447.
  • Rajita S, Fox HC, Kwang-IkAdam H, et al. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry 2011;68(9):942.
  • Yeterian JD, Greene MC, Bergman BG, Kelly JF. Does mandated treatment benefit youth? A prospective investigation of adolescent justice system involvement, treatment motivation, and substance use outcomes. Alcohol Treat Q. 2013;31(4):431–449.
  • Ashkar PJ, Kenny DT. Views from the inside: young offenders’ subjective experiences of incarceration. Int J Offender Ther Comp Criminol. 2008;52(5):584–597.
  • Lã³Pez-Pã©Rez B, Deeprose C, Hanoch Y. Prospective mental imagery as its link with anxiety and depression in prisoners. PLoS One. 2018;13(3):e0191551.
  • Lunze K, Lermet O, Andreeva V, Hariga F. Compulsory treatment of drug use in Southeast Asian countries. Int J Drug Policy. 2018;59:10–15.
  • Chen T, Zhong N, Du J, et al. Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai, China. Addiction 2019;114(2):259–267.
  • Su H, Li Z, Du J, et al. Predictors of heroin relapse: personality traits, impulsivity, COMT gene Val158met polymorphism in a 5-year prospective study in Shanghai, China. Am J Med Genet. 2015;168(8):712–719.
  • Millere A, Pūce A, Millere E, et al. Treatment motivation factor analysis of patients with substance use disorders in Latvia ⋆. Proc Soc Behav Sci. 2014;159(2014):298–302.
  • Vandercammen L, Hofmans J, Theuns P. Relating specific emotions to intrinsic motivation: on the moderating role of positive and negative emotion differentiation. PLoS One. 2014;9(12):e115396.
  • Prior K, Mills K, Ross J, Teesson M. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug Alcohol Rev. 2017;36(3):317–324.
  • Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(02):247–257.
  • Hogarth L, Mathew AR, Hitsman B. Current major depression is associated with greater sensitivity to the motivational effect of both negative mood induction and abstinence on tobacco-seeking behavior. Drug Alcohol Depend. 2017;176:1–6.
  • Fox HC, Axelrod SR, Paliwal P, Sleeper J, Sinha R. Difficulties in emotion regulation and impulse control during cocaine abstinence. Drug Alcohol Depend. 2007;89(2-3):298–301.
  • United Nations Office on Drugs and Crime, World Health Organization. World Drug Report: Global Overview of Drug Demand and Supply. In: UNODC, ed. United Nations publication. Vienna; 2018.
  • Liao M, Kang D, Tao X, et al. Syndemics of syphilis, HCV infection, and methamphetamine use along the east coast of China. BMC Public Health. 2014;14(1):172.
  • Falck RS, Wang J, Carlson RG, Siegal HA. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio. Addict Behav. 2006;31(1):90–101.
  • Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis. 2010;29(2):127–138.
  • Sharifi V, Amin-Esmaeili M, Hajebi A, et al. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Arch Iran Med. 2015;18(2):76–84.
  • Arfken CL, Klein C, Menza S, Di Schuster CR. Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat. 2001;20(1):53–57.
  • Fox HC, Sinha R. Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harv Rev Psychiatry. 2009;17(2):103–119.
  • Pelissier B, Jones N. A review of gender differences among substance abusers. Crime Delinquency. 2005;51(3):343–372.
  • Spooner C, Saktiawati AM, Lazuardi E, Worth H, Subronto YW, Padmawati RS. Impacts of stigma on HIV risk for women who inject drugs in Java: a qualitative study. Int J Drug Policy. 2015;26(12):1244–1250.
  • Bruscia K. Defining Music Therapy. 2nd ed. Gilsum, NH: Barcelona Publications; 1998.
  • Geretsegger M, Mössler KA, Bieleninik Ł, Chen XJ, Heldal TO, Gold C. Music therapy for people with schizophrenia and schizophrenia-like disorders. Cochrane Database Syst Rev. 2017;5:Cd004025.
  • Silverman MJ. Effects of lyric analysis interventions on treatment motivation in patients on a detoxification unit: a randomized effectiveness study. J Music Ther. 2015;52(1):117–134.
  • Cevasco AM, Kennedy R, Generally NR. Comparison of movement-to-music, rhythm activities, and competitive games on depression, stress, anxiety, and anger of females in substance abuse rehabilitation. J Music Ther. 2005;42(1):64–80.
  • Gold C, Solli HP, Krüger V, Lie SA. Dose-response relationship in music therapy for people with serious mental disorders: systematic review and meta-analysis. Clin Psychol Rev. 2009;29(3):193–207.
  • Mays KL, Clark DL, Gordon AJ. Treating addiction with tunes: a systematic review of music therapy for the treatment of patients with addictions. Subst Abuse. 2008;29(4):51–59.
  • Dingle GA, Gleadhill L, Baker FA. Can music therapy engage patients in group cognitive behaviour therapy for substance abuse treatment? Drug Alcohol Revs. 2008;27(2):190–196.
  • Luo W, Wu Z, Wei X, et al. Chinese assimilation of the ffh edition of Addiction severity index scale and the evaluations on its applications in addiction status investigation. Chin J Drug Depend. 2007;16:373–376.
  • Zhao M, Li X, Hao W, Wang Z, Zhang M, D X. A preliminary study of the reliability and validity of the Addiction Severity Index. Chin Med Res J. 2004;4:679–680.
  • Wu X, Zeng H, Li L, Chen Y. Designing questionnaire on motivation for abstaining from drugs. Chin J Drug Depend. 2008;17(6):465–468.
  • Wang X. Mental health assessment scale manual. Chin Mental Health J Suppl. 1999:194–195.
  • Tao M, Gao J. Reliability and vlidity of self-rating anxiety scale in Chinese version. Modern Pract Med. 1994;20(5):301–303.
  • Wang, Liu H, Z L. Reliability and validity of emotion regulation questionnaire Chinese revised version. China J Health Psychol. 2007;15(6):503–505.
  • Zhang F, Dong Y, Wang K, Zhang Z, Xie L. Reliability and validity of the Chinese version of the interpersonal reactivity index-C. Chin J Clin Psychol. 2010;18(2):155–157.
  • Silverman MJ. Effects of music therapy on change and depression on clients in detoxification. J Addict Nurs. 2011;22(4):185–192.
  • Stegemoller EL. Exploring a neuroplasticity model of music therapy. J Music Ther. 2014;51(3):211–227.
  • Wan CY, Schlaug G. Music making as a tool for promoting brain plasticity across the life span. Neuroscientist. 2010;16(5):566–577.
  • Murphy M. Music therapy: a self-help group experience for substance abuse patients. Music Ther. 1983;3(1):52–62.
  • Baker FA, Gleadhill LM, Dingle GA. Music therapy and emotional exploration: exposing substance abuse clients to the experiences of non-drug-induced emotions. Arts Psychother. 2007;34(4):321–330.
  • Albornoz Y. The effects of group improvisational music therapy on depression in adolescents and adults with substance abuse: a randomized controlled trial**. Nordic J Music Ther. 2011;20(3):208–224.
  • Stefan N, Eva K, Ulrica N, Birgitta S, Karin ER. School-aged children’s experiences of postoperative music medicine on pain, distress, and anxiety. Paediatr Anaesth. 2010;19(12):1184–1190.
  • Carr C, D’Ardenne P, Sloboda A, Scott C, Wang D, Priebe S. Group music therapy for patients with persistent post‐traumatic stress disorder – an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012;85(2):179–202.
  • Burns SJ, Harbuz MS, Hucklebridge F, Bunt L. A pilot study into the therapeutic effects of music therapy at a cancer help center. Altern Ther Health Med. 2001;7(1):48–56.
  • Baker TB, Piper ME, Mccarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33–51.
  • Battjes RJ, Gordon MS, O’Grady KE, Kinlock TW, Carswell MA. Factors that predict adolescent motivation for substance abuse treatment. J Subst Abuse Treat. 2003;24(3):221–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.